StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research note issued to investors on Saturday. The firm sets a “sell” rating on the stock.
Ayala Pharmaceuticals Trading Down 4.0 %
ADXS stock opened at